Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
BAY 73-4506
.
Show all posts
Showing posts with label
BAY 73-4506
.
Show all posts
Monday, October 31, 2011
Phase III Trial of Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival...
›
Bayer HealthCare Pharmaceuticals, announced the results from its Phase III trial evaluating its investigational compound regorafenib (see ...
›
Home
View web version
